Alangcas, Jonard M.
HRN: 29-23-22 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2026
RIFAXIMIN 200MG (TAB)
06/30/2026
07/07/2026
PO
200mg
Q12hrs
Septic/Hepatic Encephalopathy
Checking Initial Appropriateness
07/02/2026
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
07/02/2026
07/09/2026
TOPICAL
25g
BID
Abraised Wound
Checking Initial Appropriateness
07/02/2026
RIFAXIMIN 200MG (TAB)
07/02/2026
07/09/2026
ORAL
200mg
BID
Hepatic Encephalopathy
Checking Initial Appropriateness